Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Life Sci ; 153: 141-52, 2016 May 15.
Article in English | MEDLINE | ID: mdl-27085217

ABSTRACT

AIM: This study tested the hypothesis that angiotensin II (Ang II) AT1 receptor is involved in development of hypertension and cardiac fibrosis via modifying ACE2 activity, eNOS expression and CD44-hyaluronan interaction. MAIN METHODS: Male Sprague-Dawley rats were subjected to Ang II infusion (500ng/kg/min) using osmotic minipumps up to 4weeks and the AT1 receptor blocker, telmisartan was administered by gastric gavage (10mg/kg/day) during Ang II infusion. KEY FINDINGS: Our results indicated that Ang II enhances AT1 receptor, downregulates AT2 receptor, ACE2 activity and eNOS expression, and increases CD44 expression and hyaluronidase activity, an enzyme for hyaluronan degradation. Further analyses revealed that Ang II increases blood pressure and augments vascular/interstitial fibrosis. Comparison of the Ang II group, treatment with telmisartan significantly increased ACE2 activity and eNOS expression in the intracardiac vessels and intermyocardium. These changes occurred in coincidence with decreased blood pressure. Furthermore, the locally-expressed AT1 receptor was downregulated, as evidenced by an increased ratio of the AT2 over AT1 receptor (1.4±0.4% vs. 0.4±0.1% in Ang II group, P<0.05). Along with these modulations, telmisartan inhibited membrane CD44 expression and hyaluronidase activity, decreased populations of macrophages and myofibroblasts, and reduced expression of TGFß1 and Smads. Collagen I synthesis and tissue fibrosis were attenuated as demonstrated by the less extensive collagen-rich area. SIGNIFICANCE: These results suggest that the AT1 receptor is involved in development of hypertension and cardiac fibrosis. Selective activating ACE2/eNOS and inhibiting CD44/HA interaction might be considered as the therapeutic targets for attenuating Ang II induced deleterious cardiovascular effects.


Subject(s)
Cardiomyopathies/metabolism , Hyaluronan Receptors/metabolism , Hyaluronic Acid/metabolism , Hypertension/metabolism , Nitric Oxide Synthase Type III/metabolism , Peptidyl-Dipeptidase A/metabolism , Receptor, Angiotensin, Type 1/physiology , Angiotensin-Converting Enzyme 2 , Animals , Male , Rats , Rats, Sprague-Dawley
2.
Methods Mol Biol ; 397: 79-90, 2007.
Article in English | MEDLINE | ID: mdl-18025715

ABSTRACT

Detailed cytological analysis of cells undergoing differentiation often reveals clues to the regulation of multiple cell features. The Hedgehog (Hh) signaling cascade is a master regulator of cell fate during differentiation and is implicated in the development of some neoplasias. Hh signaling affects the expression of cell surface markers of differentiation. We have used the flow cytometer to evaluate the effect of blockage of the Hh signal on the expression of cell surface markers of erythroid differentiation in an in vitro system. In addition, the effect of Hh signaling on the distribution of cells in the phases of the cell cycle over the course of erythroid differentiation was assessed. Inhibition of the Hh signal retards progression of the erythroid developmental program. Included is a discussion of some of the basic parameters, limitations, and interpretations of flow cytometric analysis used for CD marker expression and cell cycle studies.


Subject(s)
Cell Cycle , Cell Membrane/metabolism , Flow Cytometry/methods , Hedgehog Proteins/metabolism , Signal Transduction , Biomarkers/metabolism , Bone Marrow Cells/cytology , Bone Marrow Cells/metabolism , CD36 Antigens/metabolism , Cell Count , Fluorescein-5-isothiocyanate/metabolism , Glycophorins/metabolism , Humans , Phycoerythrin/metabolism , Staining and Labeling
3.
Blood Cells Mol Dis ; 34(1): 60-70, 2005.
Article in English | MEDLINE | ID: mdl-15607701

ABSTRACT

Hedgehog (Hh) signaling regulates differentiation in numerous systems, but its functions in the control of hematopoietic differentiation have not been extensively explored. Initial studies have indicated that hedgehog signaling affects the proliferation and differentiation of erythroid progenitors (Detmer, K., et al., Erythroid differentiation in vitro is blocked by cyclopamine, an inhibitor of hedgehog signaling. Blood Cells Mol. Dis. 26(4) (2000) 360-372). To examine the effect of Hh signaling on the erythroid developmental program at the molecular level, Hh signaling in committed erythroid progenitors differentiating in vitro was inhibited, and the appearance/disappearance of molecular markers of erythroid differentiation was monitored. The expression timetable for CD34, CD36, the erythropoietin receptor, and glycophorin A was retarded in the absence of Hh signaling. Hemoglobinization was delayed and decreased relative to controls. Morphological changes of erythroid maturation were also delayed. The fraction of cells in S-phase was decreased during the initial period of exponential expansion as assessed by propidium iodide staining and flow cytometry, as was the rate of tritiated thymidine incorporation. A modest decrease in the proliferation rate was observed. These results suggest that Hh signaling is one of the mechanisms in the regulation of erythroid proliferation and differentiation.


Subject(s)
Cell Cycle , Cell Differentiation , Erythroid Precursor Cells/cytology , Erythroid Precursor Cells/metabolism , Signal Transduction , Trans-Activators/metabolism , Biomarkers , Cells, Cultured , Glycophorins/metabolism , Hedgehog Proteins , Hemoglobins/metabolism , Humans , Signal Transduction/drug effects , Veratrum Alkaloids/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...